Naphthol AS-BI N-acetyl-b-D-glucosaminide
CAS: 3395-37-7
Ref. 3D-EN06141
25mg | 175,00 € | ||
50mg | 237,00 € | ||
100mg | 371,00 € | ||
250mg | 660,00 € | ||
500mg | 943,00 € |
Información del producto
- 2-Naphth-o-anisidide, 3-[(2-acetamido-2-deoxy-β-<span class="text-smallcaps">D</span>-glucopyranosyl)oxy]-7-bromo-
- 2-Naphthalenecarboxamide, 3-[[2-(acetylamino)-2-deoxy-β-<span class="text-smallcaps">D</span>-glucopyranosyl]oxy]-7-bromo-N-(2-methoxyphenyl)-
- 3-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-7-bromo-N-(2-methoxyphenyl)naphthalene-2-carboxamide
- 3-[[2-(Acetylamino)-2-deoxy-β-<span class="text-smallcaps">D</span>-glucopyranosyl]oxy]-7-bromo-N-(2-methoxyphenyl)-2-naphthalenecarboxamide
- Glucopyranoside, 6-bromo-3-[(o-methoxyphenyl)carbamoyl]-2-naphthyl 2-acetamido-2-deoxy-+, β-<span class="text-smallcaps">D</span>-
Naphthol AS-BI N-acetyl-b-D-glucosaminide is an enzyme inhibitor that is used in the treatment of Gaucher's disease. The enzyme it inhibits is β-glucosidase, which breaks down glucocerebrosides in the lysosomes of cells. This drug prevents the breakdown of glucocerebrosides and increases their concentration in cells, which reduces the symptoms of Gaucher's disease. Naphthol AS-BI N-acetyl-b-D-glucosaminide has been shown to be effective against wild type and mutant forms of the enzyme. However, it does not work against patients who are homozygous for a mutation in exon 1 of the βglu gene that codes for βglu protein.
Propiedades químicas
Consulta técnica sobre: 3D-EN06141 Naphthol AS-BI N-acetyl-b-D-glucosaminide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.